Vivos therapeutics announces pricing of $24 million follow-on offering

Highlands ranch, colo., may 06, 2021 (globe newswire) -- vivos therapeutics, inc. (nasdaq: vvos) (“vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (osa), today announced the pricing of its underwritten follow-on public offering of 4,000,000 shares of its common stock at a public offering price of $6.00 per share.
VVOS Ratings Summary
VVOS Quant Ranking